Key Market Segments:
By Product & Services
-
Sample Preparation Products
-
By Workflow
-
Library Preparation and Target Enrichment
-
Quality Control
-
By Method
-
Manual Sample Preparation
-
Microfluidic Sample Preparation
-
Robotic Liquid Handling Sample Preparation
-
RNA-sequencing Platforms and Consumables
-
RNA-sequencing Services
-
Data Analysis, Storage & Management
-
Others
By Technology
-
Sequencing by Synthesis
-
Ion Semiconductor Sequencing
-
Single-molecule Real-time Sequencing
-
Nanopore Sequencing
By Application
-
Expression Profiling Analysis
-
Small RNA-sequencing
-
Variant Calling and Transcriptome Assembly
-
De Novo Transcriptome Epigenetics
By End User
-
Research and Academia
-
Hospitals and Clinics
-
Pharmaceutical and Biotechnology Companies
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Eastern Europe
-
Poland
-
Romania
-
Hungary
-
Turkey
-
Rest of Eastern Europe
-
-
Western Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Netherlands
-
Switzerland
-
Austria
-
Rest of Western Europe
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Vietnam
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
Middle East
-
UAE
-
Egypt
-
Saudi Arabia
-
Qatar
-
Rest of Middle East
-
-
Africa
-
Nigeria
-
South Africa
-
Rest of Africa
-
-
Latin America
-
Brazil
-
Argentina
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Product Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Product Matrix which gives a detailed comparison of product portfolio of each company
-
Geographic Analysis
-
Additional countries in any of the regions
-
Company Information
-
Detailed analysis and profiling of additional market players (Up to five)
Frequently Asked Questions
Growth is driven by the increasing focus on personalized medicine, rising demand for cancer genomics, advancements in sequencing technologies, and the expanding use of RNA-Seq in drug discovery and disease research.
Leading companies include Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, and QIAGEN, which offer RNA sequencing platforms and solutions for research and clinical applications.
Trends include the rise of single-cell RNA sequencing, advancements in bioinformatics tools for data analysis, increasing adoption in cancer genomics, and the growing importance of RNA-Seq in disease diagnosis and therapeutic development.
Key applications include gene expression profiling, disease research, personalized medicine, biomarker discovery, drug development, and studying non-coding RNA. RNA-Seq is used in oncology, neurology, and other medical fields for precision medicine.
The projected market size for the NGS based RNA Sequencing Market is USD 12.1 billion by 2032.